Reflecting on a Year of Hope and Progress
As the year comes to a close,…
The holidays are often painted as bright, joyful, and perfectly arranged—like strands of lights…
Winter in Nebraska can be beautiful — but it also brings challenges like cold…
ACRO’s Site Resource Grants are designed to serve as seed funding to help clinical…
Peer-reviewed analysis finds community oncology delivers high-quality care at substantially lower costs compared to…
Preliminary Safety, Efficacy and Molecular Characterization in Patients with Higher-Risk Myelodysplastic Syndrome Treated with…
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide
Read Article
Sequential Therapy…
Abstract C095: [212Pb]VMT-a-NET for somatostatin receptor subtype 2 (SSTR2)-expressing tumors: safety and preliminary efficacy…
ACE-BREAST-03: A phase 2 trial evaluating ARX788, an anti-HER2 antibody drug conjugate (ADC), for…
Purpose  •  Innovation  •  Relationship  •  Excellence
© 2026 Nebraska Cancer Specialists  • Privacy Policy • design by Chip Thompson
Meet DOT.